HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 27, 25665-25673, July 8, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: 280/27/25665    most recent M501615200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Togashi, M. Articles by Webb, P. Search for Related Content PubMed PubMed Citation Articles by Togashi, M. Articles by Webb, P. Social Bookmarking                      What's this?

Rearrangements in Thyroid Hormone Receptor Charge Clusters That Stabilize Bound 3,5',5-Triiodo-L-thyronine and Inhibit Homodimer Formation^*

Marie Togashi, Phuong Nguyen, Robert Fletterick, John D. Baxter¶, and Paul Webb||

From the Diabetes Center and the Department of Biochemistry and Biophysics, University of California, San Francisco, California 94143-0540

In this study, we investigated how thyroid hormone (3,5',5-triiodo-L-thyronine, T₃) inhibits binding of thyroid hormone receptor (TR) homodimers, but not TR-retinoid X receptor heterodimers, to thyroid hormone response elements. Specifically we asked why a small subset of TR mutations that arise in resistance to thyroid hormone syndrome inhibit both T₃ binding and formation of TR homodimers on thyroid hormone response elements. We reasoned that these mutations may affect structural elements involved in the coupling of T₃ binding to inhibition of TR DNA binding activity. Analysis of TR x-ray structures revealed that each of these resistance to thyroid hormone syndrome mutations affects a cluster of charged amino acids with potential for ionic bond formation between oppositely charged partners. Two clusters (1 and 2) are adjacent to the dimer surface at the junction of helices 10 and 11. Targeted mutagenesis of residues in Cluster 1 (Arg³³⁸, Lys³⁴², Asp³⁵¹, and Asp³⁵⁵) and Cluster 2 (Arg⁴²⁹, Arg³⁸³, and Glu³¹¹) confirmed that the clusters are required for stable T₃ binding and for optimal TR homodimer formation on DNA but also revealed that different arrangements of charged residues are needed for these effects. We propose that the charge clusters are homodimer-specific extensions of the dimer surface and further that T₃ binding promotes specific rearrangements of these surfaces that simultaneously block homodimer formation on DNA and stabilize the bound hormone. Our data yield insight into the way that T₃ regulates TR DNA binding activity and also highlight hitherto unsuspected T₃-dependent conformational changes in the receptor ligand binding domain.

Received for publication, February 11, 2005 , and in revised form, May 9, 2005.

^* This work was supported by National Institutes of Health Grants DK41482 and DK51281 (to J. D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^¶ Deputy director and consultant to Karo Bio AB, a biotechnology company with commercial interests in nuclear receptors.

^|| To whom correspondence should be addressed: Diabetes Center, University of California School of Medicine, HSW1210, 513 Parnassus Ave., San Francisco, CA 94143-0540. Tel.: 415-476-6789; Fax: 415-564-5813; E-mail: webbp{at}itsa.ucsf.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Estebanez-Perpina, L. A. Arnold, N. Jouravel, M. Togashi, J. Blethrow, E. Mar, P. Nguyen, K. J. Phillips, J. D. Baxter, P. Webb, et al. Structural Insight into the Mode of Action of a Direct Inhibitor of Coregulator Binding to the Thyroid Hormone Receptor Mol. Endocrinol., December 1, 2007; 21(12): 2919 - 2928. [Abstract] [Full Text] [PDF]

				L. F. R. Velasco, M. Togashi, P. G. Walfish, R. P. Pessanha, F. N. Moura, G. B. Barra, P. Nguyen, R. Rebong, C. Yuan, L. A. Simeoni, et al. Thyroid Hormone Response Element Organization Dictates the Composition of Active Receptor J. Biol. Chem., April 27, 2007; 282(17): 12458 - 12466. [Abstract] [Full Text] [PDF]